Cargando…
Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634461/ https://www.ncbi.nlm.nih.gov/pubmed/36339913 http://dx.doi.org/10.21037/acr-22-54 |
_version_ | 1784824495894167552 |
---|---|
author | Evans, D. Gareth R. Lunt, Lauren |
author_facet | Evans, D. Gareth R. Lunt, Lauren |
author_sort | Evans, D. Gareth R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9634461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-96344612022-11-05 Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? Evans, D. Gareth R. Lunt, Lauren AME Case Rep Editorial AME Publishing Company 2022-10-30 /pmc/articles/PMC9634461/ /pubmed/36339913 http://dx.doi.org/10.21037/acr-22-54 Text en 2022 AME Case Reports. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial Evans, D. Gareth R. Lunt, Lauren Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? |
title | Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? |
title_full | Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? |
title_fullStr | Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? |
title_full_unstemmed | Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? |
title_short | Are neurofibromatosis type 1 (NF1) patients at increased risk of meningioma and in particular malignant meningioma? |
title_sort | are neurofibromatosis type 1 (nf1) patients at increased risk of meningioma and in particular malignant meningioma? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634461/ https://www.ncbi.nlm.nih.gov/pubmed/36339913 http://dx.doi.org/10.21037/acr-22-54 |
work_keys_str_mv | AT evansdgarethr areneurofibromatosistype1nf1patientsatincreasedriskofmeningiomaandinparticularmalignantmeningioma AT luntlauren areneurofibromatosistype1nf1patientsatincreasedriskofmeningiomaandinparticularmalignantmeningioma |